6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Psychological distress
Psychological distress is described as the unpleasant emotions or sentiments that individual experiences when overcome, which can have a significant impact on daily living actions. This type of psychological anguish can cause a variety of negative feelings, including depression, interruption, and anxiety. Because of the high amounts of stress, a person is more prone to have unfriendly health conditions when this occurs. Individuals who suffer significant amounts of psychological anguish, for example, are more prone to develop cardiovascular disease, strokes, or suicidal thoughts. A person could experience psychological anguish in certain circumstances. For example, whenever a person has a distressing experience, such as a horrific accident, they will also have negative thoughts and tension. It is critical that kids receive the best possible care and, if necessary, therapy.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States